UTHR Annual EBIT
$1.33 B
+$350.60 M+35.67%
31 December 2023
Summary:
As of January 19, 2025, UTHR annual earnings before interest & taxes is $1.33 billion, with the most recent change of +$350.60 million (+35.67%) on December 31, 2023. During the last 3 years, it has risen by +$671.20 million (+101.33%). UTHR annual EBIT is now at all-time high.UTHR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Quarterly EBIT
$398.70 M
+$31.80 M+8.67%
30 September 2024
Summary:
As of January 19, 2025, UTHR quarterly earnings before interest & taxes is $398.70 million, with the most recent change of +$31.80 million (+8.67%) on September 30, 2024. Over the past year, it has increased by +$31.30 million (+8.52%). UTHR quarterly EBIT is now -45.95% below its all-time high of $737.60 million, reached on September 30, 2015.UTHR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR TTM EBIT
$1.49 B
+$31.30 M+2.15%
30 September 2024
Summary:
As of January 19, 2025, UTHR TTM earnings before interest & taxes is $1.49 billion, with the most recent change of +$31.30 million (+2.15%) on September 30, 2024. Over the past year, it has increased by +$273.80 million (+22.55%). UTHR TTM EBIT is now -3.68% below its all-time high of $1.54 billion, reached on June 30, 2016.UTHR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.7% | +8.5% | +22.6% |
| 3 y3 years | +101.3% | +8.5% | +22.6% |
| 5 y5 years | +72.6% | +121.8% | +112.8% |
UTHR EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +117.7% | -3.2% | +174.6% | at high | +142.9% |
| 5 y | 5-year | at high | +1204.0% | -3.2% | +974.7% | at high | +1331.8% |
| alltime | all time | at high | +1204.0% | -46.0% | +162.3% | -3.7% | +930.8% |
United Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $398.70 M(+8.7%) | $1.49 B(+2.1%) |
| June 2024 | - | $366.90 M(-10.9%) | $1.46 B(+1.2%) |
| Mar 2024 | - | $411.90 M(+32.7%) | $1.44 B(+8.0%) |
| Dec 2023 | $1.33 B(+35.7%) | $310.50 M(-15.5%) | $1.33 B(+9.8%) |
| Sept 2023 | - | $367.40 M(+5.0%) | $1.21 B(+3.9%) |
| June 2023 | - | $350.00 M(+14.5%) | $1.17 B(+19.8%) |
| Mar 2023 | - | $305.70 M(+60.0%) | $975.30 M(-0.8%) |
| Dec 2022 | $983.00 M(+60.5%) | $191.10 M(-40.6%) | $983.00 M(+4.9%) |
| Sept 2022 | - | $321.70 M(+105.2%) | $937.10 M(+13.7%) |
| June 2022 | - | $156.80 M(-50.0%) | $824.40 M(-7.2%) |
| Mar 2022 | - | $313.40 M(+115.8%) | $888.80 M(+45.1%) |
| Dec 2021 | $612.50 M(-7.5%) | $145.20 M(-30.5%) | $612.50 M(+4.4%) |
| Sept 2021 | - | $209.00 M(-5.5%) | $586.50 M(-2.5%) |
| June 2021 | - | $221.20 M(+496.2%) | $601.40 M(+15.7%) |
| Mar 2021 | - | $37.10 M(-68.9%) | $519.70 M(-21.5%) |
| Dec 2020 | $662.40 M(-648.3%) | $119.20 M(-46.8%) | $662.40 M(+6.6%) |
| Sept 2020 | - | $223.90 M(+60.5%) | $621.50 M(+7.9%) |
| June 2020 | - | $139.50 M(-22.4%) | $576.20 M(-17.6%) |
| Mar 2020 | - | $179.80 M(+129.6%) | $699.30 M(-678.9%) |
| Dec 2019 | -$120.80 M(-115.6%) | $78.30 M(-56.2%) | -$120.80 M(+17.4%) |
| Sept 2019 | - | $178.60 M(-32.0%) | -$102.90 M(-25.1%) |
| June 2019 | - | $262.60 M(-141.0%) | -$137.30 M(-23.3%) |
| Mar 2019 | - | -$640.30 M(-765.6%) | -$179.10 M(-123.2%) |
| Dec 2018 | $772.80 M(-0.7%) | $96.20 M(-33.3%) | $772.80 M(-5.9%) |
| Sept 2018 | - | $144.20 M(-34.7%) | $821.10 M(-18.0%) |
| June 2018 | - | $220.80 M(-29.1%) | $1.00 B(+21.2%) |
| Mar 2018 | - | $311.60 M(+115.6%) | $825.70 M(+6.1%) |
| Dec 2017 | $778.50 M(-26.8%) | $144.50 M(-55.4%) | $778.50 M(-3.6%) |
| Sept 2017 | - | $324.00 M(+610.5%) | $807.70 M(+11.7%) |
| June 2017 | - | $45.60 M(-82.8%) | $723.30 M(-25.0%) |
| Mar 2017 | - | $264.40 M(+52.2%) | $964.00 M(-9.4%) |
| Dec 2016 | $1.06 B(+1.4%) | $173.70 M(-27.5%) | $1.06 B(+1.6%) |
| Sept 2016 | - | $239.60 M(-16.3%) | $1.05 B(-32.2%) |
| June 2016 | - | $286.30 M(-21.5%) | $1.54 B(+8.2%) |
| Mar 2016 | - | $364.50 M(+132.9%) | $1.43 B(+36.1%) |
| Dec 2015 | $1.05 B(+93.3%) | $156.50 M(-78.8%) | $1.05 B(-2.0%) |
| Sept 2015 | - | $737.60 M(+334.6%) | $1.07 B(+254.4%) |
| June 2015 | - | $169.70 M(-1254.4%) | $302.19 M(-2.6%) |
| Mar 2015 | - | -$14.70 M(-108.2%) | $310.27 M(-42.8%) |
| Dec 2014 | $542.80 M(+82.8%) | $178.32 M(-672.9%) | $542.80 M(+60.9%) |
| Sept 2014 | - | -$31.12 M(-117.5%) | $337.41 M(-28.9%) |
| June 2014 | - | $177.78 M(-18.4%) | $474.26 M(+13.0%) |
| Mar 2014 | - | $217.83 M(-904.7%) | $419.52 M(+41.3%) |
| Dec 2013 | $296.96 M(-35.1%) | -$27.07 M(-125.6%) | $296.96 M(-34.5%) |
| Sept 2013 | - | $105.72 M(-14.1%) | $453.47 M(-1.6%) |
| June 2013 | - | $123.04 M(+29.1%) | $460.63 M(+3.6%) |
| Mar 2013 | - | $95.27 M(-26.4%) | $444.76 M(-2.7%) |
| Dec 2012 | $457.31 M(+42.7%) | $129.44 M(+14.7%) | $457.31 M(+16.4%) |
| Sept 2012 | - | $112.88 M(+5.3%) | $392.97 M(+2.4%) |
| June 2012 | - | $107.17 M(-0.6%) | $383.76 M(-2.0%) |
| Mar 2012 | - | $107.82 M(+65.6%) | $391.64 M(+21.9%) |
| Dec 2011 | $320.48 M | $65.10 M(-37.2%) | $321.29 M(+17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $103.67 M(-9.9%) | $272.44 M(+17.5%) |
| June 2011 | - | $115.05 M(+207.0%) | $231.92 M(+29.6%) |
| Mar 2011 | - | $37.47 M(+130.7%) | $178.94 M(+2.3%) |
| Dec 2010 | $174.86 M(+452.6%) | $16.25 M(-74.3%) | $174.84 M(+11.0%) |
| Sept 2010 | - | $63.15 M(+1.7%) | $157.52 M(+47.6%) |
| June 2010 | - | $62.07 M(+86.0%) | $106.74 M(+151.9%) |
| Mar 2010 | - | $33.37 M(-3206.9%) | $42.38 M(+33.9%) |
| Dec 2009 | $31.64 M(-143.8%) | -$1.07 M(-108.7%) | $31.64 M(-131.7%) |
| Sept 2009 | - | $12.38 M(-639.3%) | -$99.97 M(+8.1%) |
| June 2009 | - | -$2.29 M(-110.1%) | -$92.47 M(+29.9%) |
| Mar 2009 | - | $22.63 M(-117.1%) | -$71.18 M(-10.0%) |
| Dec 2008 | -$72.28 M(-485.3%) | -$132.69 M(-767.5%) | -$79.06 M(-237.1%) |
| Sept 2008 | - | $19.88 M(+4.7%) | $57.68 M(+11.0%) |
| June 2008 | - | $18.99 M(+28.7%) | $51.96 M(+26.7%) |
| Mar 2008 | - | $14.75 M(+263.4%) | $41.02 M(+118.7%) |
| Dec 2007 | $18.76 M(-35.3%) | $4.06 M(-71.3%) | $18.76 M(+2.8%) |
| Sept 2007 | - | $14.16 M(+76.0%) | $18.25 M(+17.5%) |
| June 2007 | - | $8.04 M(-207.2%) | $15.52 M(-18.3%) |
| Mar 2007 | - | -$7.50 M(-311.5%) | $18.99 M(-34.5%) |
| Dec 2006 | $28.98 M(-32.4%) | $3.55 M(-69.0%) | $28.98 M(-19.0%) |
| Sept 2006 | - | $11.43 M(-0.7%) | $35.79 M(-8.0%) |
| June 2006 | - | $11.52 M(+363.6%) | $38.89 M(+0.9%) |
| Mar 2006 | - | $2.48 M(-76.0%) | $38.54 M(-10.2%) |
| Dec 2005 | $42.89 M(+224.7%) | $10.36 M(-28.8%) | $42.89 M(+10.4%) |
| Sept 2005 | - | $14.54 M(+30.2%) | $38.85 M(+29.4%) |
| June 2005 | - | $11.16 M(+63.2%) | $30.01 M(+33.9%) |
| Mar 2005 | - | $6.84 M(+8.3%) | $22.42 M(+69.7%) |
| Dec 2004 | $13.21 M(-214.6%) | $6.31 M(+10.8%) | $13.21 M(+291.6%) |
| Sept 2004 | - | $5.70 M(+59.6%) | $3.37 M(-182.9%) |
| June 2004 | - | $3.57 M(-250.5%) | -$4.07 M(-61.1%) |
| Mar 2004 | - | -$2.37 M(-32.6%) | -$10.47 M(-9.2%) |
| Dec 2003 | -$11.53 M(-36.0%) | -$3.52 M(+102.1%) | -$11.53 M(+3.7%) |
| Sept 2003 | - | -$1.74 M(-38.4%) | -$11.12 M(-30.1%) |
| June 2003 | - | -$2.83 M(-17.6%) | -$15.91 M(+10.0%) |
| Mar 2003 | - | -$3.43 M(+10.2%) | -$14.46 M(-19.7%) |
| Dec 2002 | -$18.00 M(-61.6%) | -$3.11 M(-52.4%) | -$18.00 M(-26.2%) |
| Sept 2002 | - | -$6.54 M(+374.0%) | -$24.40 M(-18.0%) |
| June 2002 | - | -$1.38 M(-80.2%) | -$29.76 M(-28.0%) |
| Mar 2002 | - | -$6.97 M(-26.7%) | -$41.36 M(-10.6%) |
| Dec 2001 | -$46.94 M(-42.4%) | -$9.51 M(-20.0%) | -$46.28 M(-31.8%) |
| Sept 2001 | - | -$11.90 M(-8.3%) | -$67.83 M(+2.2%) |
| June 2001 | - | -$12.97 M(+9.1%) | -$66.36 M(-20.9%) |
| Mar 2001 | - | -$11.89 M(-61.7%) | -$83.91 M(+3.0%) |
| Dec 2000 | -$81.50 M(+130.5%) | -$31.07 M(+198.1%) | -$81.50 M(+36.1%) |
| Sept 2000 | - | -$10.42 M(-65.8%) | -$59.89 M(+5.9%) |
| June 2000 | - | -$30.52 M(+221.6%) | -$56.57 M(+75.4%) |
| Mar 2000 | - | -$9.49 M(+0.3%) | -$32.25 M(-8.0%) |
| Dec 1999 | -$35.36 M(+165.0%) | -$9.46 M(+33.3%) | -$35.06 M(+37.0%) |
| Sept 1999 | - | -$7.10 M(+14.5%) | -$25.60 M(+38.4%) |
| June 1999 | - | -$6.20 M(-49.6%) | -$18.50 M(+50.4%) |
| Mar 1999 | - | -$12.30 M | -$12.30 M |
| Dec 1998 | -$13.35 M | - | - |
FAQ
- What is United Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for United Therapeutics?
- What is United Therapeutics annual EBIT year-on-year change?
- What is United Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for United Therapeutics?
- What is United Therapeutics quarterly EBIT year-on-year change?
- What is United Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for United Therapeutics?
- What is United Therapeutics TTM EBIT year-on-year change?
What is United Therapeutics annual earnings before interest & taxes?
The current annual EBIT of UTHR is $1.33 B
What is the all time high annual EBIT for United Therapeutics?
United Therapeutics all-time high annual earnings before interest & taxes is $1.39 B
What is United Therapeutics annual EBIT year-on-year change?
Over the past year, UTHR annual earnings before interest & taxes has changed by +$350.60 M (+35.67%)
What is United Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of UTHR is $398.70 M
What is the all time high quarterly EBIT for United Therapeutics?
United Therapeutics all-time high quarterly earnings before interest & taxes is $737.60 M
What is United Therapeutics quarterly EBIT year-on-year change?
Over the past year, UTHR quarterly earnings before interest & taxes has changed by +$31.30 M (+8.52%)
What is United Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of UTHR is $1.49 B
What is the all time high TTM EBIT for United Therapeutics?
United Therapeutics all-time high TTM earnings before interest & taxes is $1.54 B
What is United Therapeutics TTM EBIT year-on-year change?
Over the past year, UTHR TTM earnings before interest & taxes has changed by +$273.80 M (+22.55%)